The briefing
India’s Supreme Court pressed for extending a 30% trade-margin cap beyond cancer therapies to all essential medicines and key medical products. The court urged stronger enforcement under the drug pricing framework to improve patient affordability.
Original headline
Supreme Court wants cap on trade margin for all essential medicines and medical products